Unraveling Dexamethasone-Induced Neurobehavioral and Sleep Problems in Children With ALL: Which Determinants Are Important?
JCO Precision Oncology · 2023
DOI: 10.1200/po.22.00678 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCO Precision Oncology, 2023. Verfasst von Annelienke M van Hulst und 11 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Oncology, Princess Máxima Center, Utrecht, the Netherlands. Hauptthemen laut MEDLINE: Sleep Wake Disorders, Precursor Cell Lymphoblastic Leukemia-Lymphoma. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
PURPOSE Dexamethasone, the preferred corticosteroid in most treatment protocols for pediatric acute lymphoblastic leukemia (ALL), can induce undesirable side effects. Neurobehavioral and sleep problems are frequently reported, but the interpatient variability is high. We therefore aimed to identify determinants for parent-reported dexamethasone-induced neurobehavioral and sleep problems in pediatric ALL. METHODS Our prospective study included patients with medium-risk ALL and their parents during maintenance treatment. Patients were assessed before and after one 5-day dexamethasone course. Primary end points were parent-reported dexamethasone-induced neurobehavioral and sleep problems, measured with the Strengths and Difficulties Questionnaire and Sleep Disturbance Scale for Children, respectively. Analyzed determinants included patient and parent demographics, disease and treatment characteristics, parenting stress (Parenting Stress Index and Distress Thermometer for Parents), dexamethasone pharmacokinetics, and genetic variation (candidate single-nucleotide polymorphisms rs41423247 and rs4918). Statistically significant determinants identified in univariable logistic regression analyses were incorporated in a multivariable model. RESULTS We included 105 patients: median age was 5.4 years (range, 3.0-18.8) and 61% were boys. Clinically relevant dexamethasone-induced neurobehavioral and sleep problems were reported by parents in 70 (67%) and 61 (59%) patients, respectively. In our multivariable regression models, we identified parenting stress as a significant determinant for parent-reported neurobehavioral (odds ratio [OR], 1.16; 95% CI, 1.07 to 1.26) and sleep problems (OR, 1.06; 95% CI, 1.02 to 1.10). Furthermore, parents who experienced more stress before start of a dexamethasone course reported more sleep problems in their child (OR, 1.16; 95% CI, 1.02 to 1.32). CONCLUSION We identified parenting stress, and not dexamethasone pharmacokinetics, genetic variation, patient/parent demographics, or disease/treatment characteristics, as a significant determinant for parent-reported dexamethasone-induced neurobehavioral and sleep problems. Parenting stress may be a modifiable target to reduce these problems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Pediatric Oncology, Princess Máxima Center, Utrecht, the Netherlands.
- Department of Hospital Pharmacy, Erasmus Medical Center, Rotterdam, the Netherlands.
- Division of Endocrinology, Department of Internal Medicine, Erasmus Medical Center, Rotterdam, the Netherlands.
- Department of Internal Medicine, Erasmus Medical Center, Rotterdam, the Netherlands.
- Mathematical Institute, Leiden University, Leiden, the Netherlands.
- Department of Biomedical Data Science, Medical Statistics, Leiden University Medical Centre, Leiden, the Netherlands.
ORCID-Profile: Annelienke M van Hulst, Emma J Verwaaijen, Raphaële R L van Litsenburg, Letao Li, Bertrand D van Zelst, Linda Broer, Rob Pieters, Marta Fiocco
Zitieren
APA
van Hulst, A. M., Grootenhuis, M. A., Verwaaijen, E. J., van Litsenburg, R. R. L., Li, L., van Zelst, B. D., Broer, L., Pluijm, S. M. F., Pieters, R., Fiocco, M., van den Akker, E. L. T., & van den Heuvel-Eibrink, M. M. (2023). Unraveling Dexamethasone-Induced Neurobehavioral and Sleep Problems in Children With ALL: Which Determinants Are Important?. JCO Precision Oncology. https://doi.org/10.1200/po.22.00678
Vancouver
van Hulst AM, Grootenhuis MA, Verwaaijen EJ, van Litsenburg RRL, Li L, van Zelst BD, et al. Unraveling Dexamethasone-Induced Neurobehavioral and Sleep Problems in Children With ALL: Which Determinants Are Important?. JCO Precision Oncology. 2023. doi:10.1200/po.22.00678
BibTeX
@article{vanHulst2023,
author = {van Hulst, Annelienke M and Grootenhuis, Martha A and Verwaaijen, Emma J and van Litsenburg, Raphaële R L and Li, Letao and van Zelst, Bertrand D and Broer, Linda and Pluijm, Saskia M F and Pieters, Rob and Fiocco, Marta and van den Akker, Erica L T and van den Heuvel-Eibrink, Marry M},
title = {Unraveling Dexamethasone-Induced Neurobehavioral and Sleep Problems in Children With ALL: Which Determinants Are Important?},
journal = {JCO Precision Oncology},
year = {2023},
doi = {10.1200/po.22.00678}
}
EUVIMED